As of 2025-07-04, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (70.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -274.9%.
The range of the Relative Valuation is (46.87) - (92.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 27.0x | 20.0x |
| Forward P/E multiples | 13.7x - 28.8x | 21.2x |
| Fair Price | (46.87) - (92.37) | (70.65) |
| Upside | -216.0% - -328.7% | -274.9% |
| Date | P/E |